398 related articles for article (PubMed ID: 26283663)
1. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
Coelho L; Cardoso SW; Luz PM; Hoffman RM; Mendonça L; Veloso VG; Currier JS; Grinsztejn B; Lake JE
Nutr J; 2015 Aug; 14():81. PubMed ID: 26283663
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
3. Effect of high-dose cholecalciferol (vitamin D
Rovner AJ; Stallings VA; Rutstein R; Schall JI; Leonard MB; Zemel BS
Osteoporos Int; 2017 Jan; 28(1):201-209. PubMed ID: 27837268
[TBL] [Abstract][Full Text] [Related]
4. Cholecalciferol supplementation in HIV-infected youth with vitamin D insufficiency: effects on vitamin D status and T-cell phenotype: a randomized controlled trial.
Giacomet V; Vigano A; Manfredini V; Cerini C; Bedogni G; Mora S; Borelli M; Trabattoni D; Zuccotti GV
HIV Clin Trials; 2013; 14(2):51-60. PubMed ID: 23611825
[TBL] [Abstract][Full Text] [Related]
5. Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.
Ezeamama AE; Guwatudde D; Wang M; Bagenda D; Kyeyune R; Sudfeld C; Manabe YC; Fawzi WW
Clin Nutr; 2016 Oct; 35(5):1110-7. PubMed ID: 26371397
[TBL] [Abstract][Full Text] [Related]
6. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
Regalado Lam Chew Tun R; Porhownik N; Taback S; Oleschuk C
Clin Nutr ESPEN; 2018 Feb; 23():84-88. PubMed ID: 29460819
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Hoffman RM; Lake JE; Wilhalme HM; Tseng CH; Currier JS
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):247-54. PubMed ID: 26569649
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.
Nylén H; Habtewold A; Makonnen E; Yimer G; Bertilsson L; Burhenne J; Diczfalusy U; Aklillu E
Medicine (Baltimore); 2016 Aug; 95(34):e4631. PubMed ID: 27559961
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.
Eckard AR; Thierry-Palmer M; Silvestrov N; Rosebush JC; O'Riordan MA; Daniels JE; Uribe-Leitz M; Labbato D; Ruff JH; Singh RJ; Tangpricha V; McComsey GA
J Steroid Biochem Mol Biol; 2017 Apr; 168():38-48. PubMed ID: 28161530
[TBL] [Abstract][Full Text] [Related]
10. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
Poowuttikul P; Thomas R; Hart B; Secord E
J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
[TBL] [Abstract][Full Text] [Related]
12. Determination of optimal vitamin D3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach.
Foissac F; Meyzer C; Frange P; Chappuy H; Benaboud S; Bouazza N; Friedlander G; Souberbielle JC; Urien S; Blanche S; Tréluyer JM
Br J Clin Pharmacol; 2014 Nov; 78(5):1113-21. PubMed ID: 24902982
[TBL] [Abstract][Full Text] [Related]
13. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy.
Cervero M; Agud JL; García-Lacalle C; Alcázar V; Torres R; Jusdado JJ; Moreno Guillén S
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):963-71. PubMed ID: 22242918
[TBL] [Abstract][Full Text] [Related]
15. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D levels in Swiss breast cancer survivors.
Baumann M; Dani SU; Dietrich D; Hochstrasser A; Klingbiel D; Mark MT; Riesen WF; Ruhstaller T; Templeton AJ; Thürlimann B
Swiss Med Wkly; 2018; 148():w14576. PubMed ID: 29376548
[TBL] [Abstract][Full Text] [Related]
17. Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.
Muhihi A; Fawzi WW; Aboud S; Nagu TJ; Ulenga N; Wang M; Mugusi F; Sudfeld CR
J Nutr; 2022 Aug; 152(8):1983-1990. PubMed ID: 35460249
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy.
Sudfeld CR; Wang M; Aboud S; Giovannucci EL; Mugusi FM; Fawzi WW
PLoS One; 2012; 7(6):e40036. PubMed ID: 22768212
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
[TBL] [Abstract][Full Text] [Related]
20. Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Wohl DA; Orkin C; Doroana M; Pilotto JH; Sungkanuparph S; Yeni P; Vanveggel S; Deckx H; Boven K
Antivir Ther; 2014; 19(2):191-200. PubMed ID: 24430534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
